DARLING, Ryan James,DICKINSON, Craig Duane,DRIVER, David Albert,GONCIARZ, Malgorzata Donata
申请号：
ES13730733
公开号：
ES2644787T3
申请日:
2013.06.05
申请国别(地区):
ES
年份:
2017
代理人:
摘要：
This present invention relates to pharmacologically potent and stable human fibroblast growth factor 21 (FGF21) proteins, pharmaceutical compositions comprising FGF21 proteins, and methods for treating type 2 diabetes, obesity, dyslipidemia, and/or metabolic syndrome using such proteins.
